134
Participants
Start Date
November 16, 2020
Primary Completion Date
January 3, 2022
Study Completion Date
January 3, 2022
Sodium Zirconium Cyclosilicate
Suspension administered orally for a treatment period of eight weeks (4 weeks of dose adjustment, 4 weeks in stable dose) Single dose contains from 1 to 3 sachets of SZC 5g depending on dose level assigned to a patient per non-dialysis days.
Placebo
Suspension administered orally for a treatment period of eight weeks (4 weeks of dose adjustment, 4 weeks in stable dose) Single dose contains from 1 to 3 sachets of Placebo depending on dose level assigned to a patient per non-dialysis days.
Research Site, Baotou
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Changchun
Research Site, Changchun
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Yangzhou
Research Site, Hefei
Research Site, Jinan
Research Site, Tianjin
Research Site, Hangzhou
Research Site, Ningbo
Research Site, Ningbo
Research Site, Wenzhou
Research Site, Wenzhou
Research Site, Nanchang
Research Site, Shenzhen
Research Site, Shenzhen
Research Site, Dongguan
Research Site, Lanzhou
Research Site, Lanzhou
Research Site, Yinchuan
Research Site, Baotou
Research Site, Hohhot
Research Site, Ürümqi
Lead Sponsor
AstraZeneca
INDUSTRY